Clinical Trial Update: A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)

View source ↗

Summary

This clinical trial update indicates that a BioMarin-sponsored study assessing subjects with Morquio syndrome (MPS IVA) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Iva

Drugs mentioned

• Elosulfase alfa (Arylsulfatase B)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: MPS IV A, Mucopolysaccharidosis IVA | Status: TERMINATED